Viewing Study NCT06723756


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2026-03-03 @ 12:38 AM
Study NCT ID: NCT06723756
Status: COMPLETED
Last Update Posted: 2025-06-05
First Post: 2024-12-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Exposure of Budesonide, Glycopyrronium, and Formoterol (BGF) Delivered by Hydrofluoroolefin (HFO) Propellant Metered Dose Inhaler (MDI) Compared to a Hydrofluoroalkane (HFA) Propellant MDI in Healthy Adults
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D598AC00001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View